
ANAVEX LIFE SCIENCES CORP. — Investor Relations & Filings
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for central nervous system (CNS) disorders. The company develops targeted drug candidates for neurodegenerative and neurodevelopmental diseases, including Alzheimer's disease, Parkinson's disease, and Rett syndrome. Anavex's approach is centered on precision medicine, utilizing small molecule drugs designed to restore cellular homeostasis. Its lead investigational compound, blarcamesine (ANAVEX®2-73), is an orally available sigma-1 receptor (S1R) agonist being evaluated for its potential to treat a range of neurological conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-22 | English | |
| FORM 8-K | 2026-05-15 | English | |
| 8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer) | 2026-05-06 | English | |
| 8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer) | 2026-02-25 | English | |
| 10-Q - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer) | 2026-02-09 | English | |
| 8-K Filing | 2026-02-09 | English |
Browse filings by year
22 years- 2026 8 filings
- 2025 33 filings
- 2024 28 filings
- 2023 22 filings
- 2022 25 filings
- 2021 37 filings
- 2020 26 filings
- 2019 25 filings
- 2018 24 filings
- 2017 44 filings
- 2016 34 filings
- 2015 39 filings
- 2014 27 filings
- 2013 20 filings
- 2012 13 filings
- 2011 36 filings
- 2010 34 filings
- 2009 19 filings
- 2008 20 filings
- 2007 26 filings
- 2006 19 filings
- 2005 18 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 46818779 | FORM 8-K | 2026-05-22 | English | ||
| 46362355 | FORM 8-K | 2026-05-15 | English | ||
| 41807791 | 8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer) | 2026-05-06 | English | ||
| 32889910 | 8-K - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer) | 2026-02-25 | English | ||
| 18400153 | 10-Q - ANAVEX LIFE SCIENCES CORP. (0001314052) (Filer) | 2026-02-09 | English | ||
| 28810074 | 8-K Filing | 2026-02-09 | English | ||
| 28810085 | 4 Filing | 2026-01-09 | English | ||
| 28810071 | 4 Filing | 2026-01-09 | English | ||
|
2025
7 filings
| |||||
| 11802190 | FORM 10-K | 2025-11-25 | English | ||
| 11802192 | FORM 8-K | 2025-11-25 | English | ||
| 11802193 | FORM 8-K | 2025-11-14 | English | ||
| 11802194 | Director's Dealing 2025 | 2025-10-04 | English | ||
| 11802195 | Director's Dealing 2025 | 2025-10-04 | English | ||
| 11802198 | Director's Dealing 2025 | 2025-09-13 | English | ||
| 11802200 | Director's Dealing 2025 | 2025-08-22 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
89bio, Inc.
Clinical-stage biopharma developing therapies for liver and…
|
ETNB | US | Manufacturing |
|
Aardvark Therapeutics, Inc.
Clinical-stage biopharma developing therapeutics for hunger…
|
AARD | US | Manufacturing |
|
Aarey Drugs & Pharmaceuticals Ltd
Manufactures APIs and chemical intermediates for global pha…
|
AAREYDRUGS | IN | Manufacturing |
|
Aarti Drugs Limited
Produces APIs, pharma intermediates, and specialty chemical…
|
AARTIDRUGS | IN | Manufacturing |
|
Aarti Pharmalabs Limited
Manufacturer of APIs, intermediates, and xanthines with glo…
|
AARTIPHARM | IN | Manufacturing |
|
AAYUSH WELLNESS LIMITED
Develops and markets herbal formulations, supplements, and …
|
539528 | IN | Manufacturing |
|
Ab&B Bio-Tech CO., LTD. JS
Biopharmaceutical company engaged in the R&D and commercial…
|
2627 | HK | Manufacturing |
|
Abbisko Cayman Limited
Clinical-stage biopharma focused on discovering and develop…
|
2256 | KY | Manufacturing |
|
Abbott India Ltd.
Provides pharmaceutical solutions in gastroenterology, card…
|
ABBOTINDIA | IN | Manufacturing |
|
ABBOTT LABORATORIES
Global healthcare company in medical devices, diagnostics, …
|
ABT | US | Manufacturing |
ANAVEX LIFE SCIENCES CORP. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32464/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32464 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32464 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32464 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32464}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ANAVEX LIFE SCIENCES CORP. (id: 32464)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.